{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:34:20Z","timestamp":1761514460818},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Application Research and Demonstration & Promotion of Hainan Province","award":["No. ZDXM2014074"],"award-info":[{"award-number":["No. ZDXM2014074"]}]},{"name":"the Medical Science and Technology Project of Zhejiang Province","award":["No. 2017KYB521"],"award-info":[{"award-number":["No. 2017KYB521"]}]},{"name":"the Key Project of Medical Science and Technology Program of Hangzhou Health and Family Planning Commission","award":["No. 2018Z01"],"award-info":[{"award-number":["No. 2018Z01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To evaluate the safety and feasibility of selective occlusion of the hepatic artery and portal vein (SOAP) for staged hepatectomy (SOAPS) in patients with hepatocellular carcinoma (HCC)<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From December 2014 to August 2018, 9 patients with unresectable HCC were chosen to undergo SOAPS. SOAP without liver partition was performed in the first stage. The second stage was performed when future liver remnant (FLR) was equal to or bigger than 40% of the standard liver volume (SLV). The growth rate of FLR, perioperative outcomes, and survival data was recorded.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the first stage, all the 9 patients completed SOAP. Two cases received radiological interventional method and 7 cases received open operation. None of them developed liver failure and died following SOAP. After SOAP, FLR increased 145.0 ml (115.0 to 210 ml) and 37.1% (25.6 to 51.7%) on average. The average time interval between the two stages was 14.1 days (8 to 18 days). In the second stage, no in-hospital deaths occurred after SOAPS. One patient suffered from liver failure after SOAPS, and artificial liver support was adopted and his total bilirubin level returned to normal after postoperative day 35. The alpha-fetoprotein level of 8 patients reduced to normal within 2 months after SOAPS. Among 9 patients, 5 patients survived, 4 patients died of intrahepatic recurrence, lung metastasis, or bone metastasis. In the 5 survived cases, bone metastasis and intrahepatic recurrence were found in 1 patient, intrahepatic recurrence was found in another patient, and the remaining 3 patients were free of recurrence. The median disease-free survival time and overall survival time were 10.4 and 13.9 months, respectively.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>SOAP can facilitate rapid and sustained FLR hypertrophy, and SOAPS is safe and effective in patients with unresectable HCC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-019-1710-9","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T18:03:38Z","timestamp":1570471418000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Selective occlusion of the hepatic artery and portal vein improves liver hypertrophy for staged hepatectomy"],"prefix":"10.1186","volume":"17","author":[{"given":"Changku","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunbing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"key":"1710_CR1","doi-asserted-by":"publisher","first-page":"8478","DOI":"10.3748\/wjg.v21.i28.8478","volume":"21","author":"A Schlachterman","year":"2015","unstructured":"Schlachterman A, Craft WW Jr, Hilgenfeldt E, Mitra A, Cabrera R. Current and future treatments for hepatocellular carcinoma. World J Gastroenterol. 2015;21:8478\u201391.","journal-title":"World J Gastroenterol"},{"key":"1710_CR2","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020\u20132.","journal-title":"Hepatology"},{"key":"1710_CR3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/archsurg.140.5.450","volume":"140","author":"TM Pawlik","year":"2005","unstructured":"Pawlik TM, Poon RT, Abdalla EK, Zorzi D, Ikai I, Curley SA, Nagorney DM, Belghiti J, Ng IO, Yamaoka Y, et al. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg. 2005;140:450\u20137; discussion 457-458.","journal-title":"Arch Surg"},{"key":"1710_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.21037\/tgh.2017.03.13","volume":"2","author":"GM Ettorre","year":"2017","unstructured":"Ettorre GM, Levi Sandri GB, Colasanti M, Masciana G, de Werra E, Santoro R, Lepiane P, Montalbano M, Antonini M, Vennarecci G. Liver resection for hepatocellular carcinoma > 5 cm. Transl Gastroenterol Hepatol. 2017;2:22.","journal-title":"Transl Gastroenterol Hepatol"},{"key":"1710_CR5","unstructured":"Wang Z, Peng Y, Hu J, Wang X, Sun H, Sun J, Shi Y, Xiao Y, Ding Z, Yang X, et al. Associating liver partition and portal vein ligation for staged hepatectomy for unresectable hepatitis b virus-related hepatocellular carcinoma: a single center study of 45 patients. Ann Surg. 2018."},{"key":"1710_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/1073274817744621","volume":"25","author":"ST Orcutt","year":"2018","unstructured":"Orcutt ST, Anaya DA. Liver resection and surgical strategies for management of primary liver cancer. Cancer Control. 2018;25:1073274817744621.","journal-title":"Cancer Control"},{"key":"1710_CR7","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1016\/j.jceh.2014.07.002","volume":"4","author":"H Ramesh","year":"2014","unstructured":"Ramesh H. Resection for hepatocellular carcinoma. J Clin Exp Hepatol. 2014;4:S90\u20136.","journal-title":"J Clin Exp Hepatol"},{"key":"1710_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000367739","volume":"4","author":"M Tsurusaki","year":"2015","unstructured":"Tsurusaki M, Murakami T. Surgical and locoregional therapy of HCC: TACE. Liver Cancer. 2015;4:165\u201375.","journal-title":"Liver Cancer"},{"key":"1710_CR9","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s00270-011-0224-9","volume":"35","author":"S Takaki","year":"2012","unstructured":"Takaki S, Sakaguchi H, Anai H, Tanaka T, Yamamoto K, Morimoto K, Nishiofuku H, Inoue M, Sueyoshi S, Nagata T, et al. Long-term outcome of transcatheter subsegmental and segmental arterial chemoemobolization using lipiodol for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2012;35:544\u201354.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1710_CR10","first-page":"521","volume":"107","author":"M Makuuchi","year":"1990","unstructured":"Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, Yamazaki S, Hasegawa H, Ozaki H. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521\u20137.","journal-title":"Surgery"},{"key":"1710_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jamcollsurg.2013.03.004","volume":"217","author":"J Shindoh","year":"2013","unstructured":"Shindoh J, Vauthey JN, Zimmitti G, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Aloia TA. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg. 2013;217:126\u201333; discussion 133-124.","journal-title":"J Am Coll Surg"},{"key":"1710_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/SLA.0b013e31824856f5","volume":"255","author":"AA Schnitzbauer","year":"2012","unstructured":"Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Horbelt R, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255:405\u201314.","journal-title":"Ann Surg"},{"key":"1710_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003941","volume":"95","author":"YL Cai","year":"2016","unstructured":"Cai YL, Song PP, Tang W, Cheng NS. An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence. Medicine (Baltimore). 2016;95:e3941.","journal-title":"Medicine (Baltimore)"},{"key":"1710_CR14","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1097\/SLA.0b013e318265fd64","volume":"256","author":"S Dokmak","year":"2012","unstructured":"Dokmak S, Belghiti J. Which limits to the \u201cALPPS\u201d approach? Ann Surg. 2012;256:e6; author reply e16-17.","journal-title":"Ann Surg"},{"key":"1710_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1055\/s-0033-1356364","volume":"52","author":"S Nadalin","year":"2014","unstructured":"Nadalin S, Capobianco I, Li J, Girotti P, Konigsrainer I, Konigsrainer A. Indications and limits for associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Lessons learned from 15 cases at a single centre. Z Gastroenterol. 2014;52:35\u201342.","journal-title":"Z Gastroenterol"},{"key":"1710_CR16","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.1840210515","volume":"21","author":"K Urata","year":"1995","unstructured":"Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, Momose Y, Komiyama A, Makuuchi M. Calculation of child and adult standard liver volume for liver transplantation. Hepatology. 1995;21:1317\u201321.","journal-title":"Hepatology"},{"key":"1710_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00534-005-0999-7","volume":"12","author":"SM Strasberg","year":"2005","unstructured":"Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg. 2005;12:351\u20135.","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"1710_CR18","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.3892\/ol.2017.5919","volume":"13","author":"H Zou","year":"2017","unstructured":"Zou H, Tao Y, Wang ZM. Integration of Child-Pugh score with future liver remnant yields improved prediction of liver dysfunction risk for HBV-related hepatocellular carcinoma following hepatic resection. Oncol Lett. 2017;13:3631\u20137.","journal-title":"Oncol Lett"},{"key":"1710_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/SLA.0b013e318296c732","volume":"258","author":"K Slankamenac","year":"2013","unstructured":"Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien PA. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013;258:1\u20137.","journal-title":"Ann Surg"},{"key":"1710_CR20","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/01.sla.0000189131.90876.9e","volume":"242","author":"S Balzan","year":"2005","unstructured":"Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, Durand F. The \u201c50-50 criteria\u201d on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824\u20138, discussion 828-829.","journal-title":"Ann Surg"},{"key":"1710_CR21","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1245\/s10434-010-1423-3","volume":"18","author":"H Yoo","year":"2011","unstructured":"Yoo H, Kim JH, Ko GY, Kim KW, Gwon DI, Lee SG, Hwang S. Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma. Ann Surg Oncol. 2011;18:1251\u20137.","journal-title":"Ann Surg Oncol"},{"key":"1710_CR22","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/bjs.5341","volume":"93","author":"S Ogata","year":"2006","unstructured":"Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg. 2006;93:1091\u20138.","journal-title":"Br J Surg"},{"key":"1710_CR23","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s002689900050","volume":"20","author":"EC Lai","year":"1996","unstructured":"Lai EC, Fan ST, Lo CM, Chu KM, Liu CL. Anterior approach for difficult major right hepatectomy. World J Surg. 1996;20:314\u20137; discussion 318.","journal-title":"World J Surg"},{"key":"1710_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00000658-200007000-00004","volume":"232","author":"CL Liu","year":"2000","unstructured":"Liu CL, Fan ST, Lo CM, Tung-Ping Poon R, Wong J. Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg. 2000;232:25\u201331.","journal-title":"Ann Surg"},{"key":"1710_CR25","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/bjs.10196","volume":"103","author":"YJ Chang","year":"2016","unstructured":"Chang YJ, Chung KP, Chang YJ, Chen LJ. Long-term survival of patients undergoing liver resection for very large hepatocellular carcinomas. Br J Surg. 2016;103:1513\u201320.","journal-title":"Br J Surg"},{"key":"1710_CR26","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1245\/s10434-012-2450-z","volume":"19","author":"A Cucchetti","year":"2012","unstructured":"Cucchetti A, Cescon M, Ercolani G, Bigonzi E, Torzilli G, Pinna AD. A comprehensive meta-regression analysis on outcome of anatomic resection versus nonanatomic resection for hepatocellular carcinoma. Ann Surg Oncol. 2012;19:3697\u2013705.","journal-title":"Ann Surg Oncol"},{"key":"1710_CR27","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.biopha.2016.12.136","volume":"88","author":"C Jia","year":"2017","unstructured":"Jia C, Weng J, Qin Q, Chen Y, Huang X, Fu Y. Anatomic trisegmentectomy: an alternative treatment for huge or multiple hepatocellular carcinoma of right liver. Biomed Pharmacother. 2017;88:684\u20138.","journal-title":"Biomed Pharmacother"},{"key":"1710_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007864","volume":"96","author":"D Wu","year":"2017","unstructured":"Wu D, Chen E, Liang T, Wang M, Chen B, Lang B, Tang H. Predicting the risk of postoperative liver failure and overall survival using liver and spleen stiffness measurements in patients with hepatocellular carcinoma. Medicine (Baltimore). 2017;96:e7864.","journal-title":"Medicine (Baltimore)"},{"key":"1710_CR29","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/j.1478-3231.2008.01777.x","volume":"28","author":"MA van den Broek","year":"2008","unstructured":"van den Broek MA, Olde Damink SW, Dejong CH, Lang H, Malago M, Jalan R, Saner FH. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment. Liver Int. 2008;28:767\u201380.","journal-title":"Liver Int"},{"key":"1710_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000364836","volume":"31","author":"KP Cieslak","year":"2014","unstructured":"Cieslak KP, Runge JH, Heger M, Stoker J, Bennink RJ, van Gulik TM. New perspectives in the assessment of future remnant liver. Dig Surg. 2014;31:255\u201368.","journal-title":"Dig Surg"},{"key":"1710_CR31","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1111\/j.1440-1746.2005.03949.x","volume":"20","author":"Y Yamagishi","year":"2005","unstructured":"Yamagishi Y, Saito H, Tada S, Horie Y, Kato S, Ishii H, Shimojima N, Haga J, Shimazu M, Kitajima M, Hibi T. Value of computed tomography-derived estimated liver volume\/standard liver volume ratio for predicting the prognosis of adult fulminant hepatic failure in Japan. J Gastroenterol Hepatol. 2005;20:1843\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"1710_CR32","doi-asserted-by":"publisher","first-page":"W153","DOI":"10.2214\/AJR.07.2181","volume":"189","author":"XP Zhou","year":"2007","unstructured":"Zhou XP, Lu T, Wei YG, Chen XZ. Liver volume variation in patients with virus-induced cirrhosis: findings on MDCT. AJR Am J Roentgenol. 2007;189:W153\u20139.","journal-title":"AJR Am J Roentgenol"},{"key":"1710_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11684-012-0223-5","volume":"6","author":"C Tong","year":"2012","unstructured":"Tong C, Xu X, Liu C, Zhang T, Qu K. Assessment of liver volume variation to evaluate liver function. Front Med. 2012;6:421\u20137.","journal-title":"Front Med"},{"key":"1710_CR34","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1007\/s11605-012-2132-y","volume":"17","author":"J Li","year":"2013","unstructured":"Li J, Girotti P, Konigsrainer I, Ladurner R, Konigsrainer A, Nadalin S. ALPPS in right trisectionectomy: a safe procedure to avoid postoperative liver failure? J Gastrointest Surg. 2013;17:956\u201361.","journal-title":"J Gastrointest Surg"},{"key":"1710_CR35","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s11605-012-2092-2","volume":"17","author":"FA Alvarez","year":"2013","unstructured":"Alvarez FA, Ardiles V, Sanchez Claria R, Pekolj J, de Santibanes E. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): tips and tricks. J Gastrointest Surg. 2013;17:814\u201321.","journal-title":"J Gastrointest Surg"},{"key":"1710_CR36","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/SLA.0000000000001450","volume":"262","author":"E Schadde","year":"2015","unstructured":"Schadde E, Raptis DA, Schnitzbauer AA, Ardiles V, Tschuor C, Lesurtel M, Abdalla EK, Hernandez-Alejandro R, Jovine E, Machado M, et al. Prediction of mortality after ALPPS stage-1: an analysis of 320 patients from the international ALPPS registry. Ann Surg. 2015;262:780\u20135; discussion 785-786.","journal-title":"Ann Surg"},{"key":"1710_CR37","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/SLA.0000000000001046","volume":"261","author":"FA Alvarez","year":"2015","unstructured":"Alvarez FA, Ardiles V, de Santibanes M, Pekolj J, de Santibanes E. Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single center. Ann Surg. 2015;261:723\u201332.","journal-title":"Ann Surg"},{"key":"1710_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4240\/wjgs.v8.i2.124","volume":"8","author":"J Li","year":"2016","unstructured":"Li J, Ewald F, Gulati A, Nashan B. Associating liver partition and portal vein ligation for staged hepatectomy: from technical evolution to oncological benefit. World J Gastrointest Surg. 2016;8:124\u201333.","journal-title":"World J Gastrointest Surg"},{"key":"1710_CR39","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1097\/SLA.0000000000001087","volume":"261","author":"H Petrowsky","year":"2015","unstructured":"Petrowsky H, Gyori G, de Oliveira M, Lesurtel M, Clavien PA. Is partial-ALPPS safer than ALPPS? A single-center experience. Ann Surg. 2015;261:e90\u20132.","journal-title":"Ann Surg"},{"key":"1710_CR40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.surg.2016.07.029","volume":"161","author":"ACY Chan","year":"2017","unstructured":"Chan ACY, Chok K, Dai JWC, Lo CM. Impact of split completeness on future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma: Complete-ALPPS versus partial-ALPPS. Surgery. 2017;161:357\u201364.","journal-title":"Surgery"},{"key":"1710_CR41","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/bjs.9547","volume":"101","author":"R Robles","year":"2014","unstructured":"Robles R, Parrilla P, Lopez-Conesa A, Brusadin R, de la Pena J, Fuster M, Garcia-Lopez JA, Hernandez E. Tourniquet modification of the associating liver partition and portal ligation for staged hepatectomy procedure. Br J Surg. 2014;101:1129\u201334 discussion 1134.","journal-title":"Br J Surg"},{"key":"1710_CR42","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1097\/SLA.0000000000000609","volume":"261","author":"E Schadde","year":"2015","unstructured":"Schadde E, Clavien PA. Reply to letter: \u201caccelerated liver hypertrophy ALPPS and more!\u201d. Ann Surg. 2015;261:e46\u20137.","journal-title":"Ann Surg"},{"key":"1710_CR43","doi-asserted-by":"crossref","unstructured":"Jiao LR, Fajardo Puerta AB, Gall TMH, Sodergren MH, Frampton AE: Rapid Induction of Liver Regeneration for Major Hepatectomy (REBIRTH): a randomized controlled trial of portal vein embolisation versus ALPPS assisted with radiofrequency. 2019, 11.","DOI":"10.3390\/cancers11030302"},{"key":"1710_CR44","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1097\/SLA.0000000000002511","volume":"267","author":"P Sandstrom","year":"2018","unstructured":"Sandstrom P, Rosok BI, Sparrelid E, Larsen PN, Larsson AL, Lindell G, Schultz NA, Bjornbeth BA, Isaksson B, Rizell M, Bjornsson B. ALPPS improves resectability compared with conventional two-stage hepatectomy in patients with advanced colorectal liver metastasis: results from a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial). Ann Surg. 2018;267:833\u201340.","journal-title":"Ann Surg"},{"key":"1710_CR45","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015229","volume":"98","author":"Y Liu","year":"2019","unstructured":"Liu Y, Yang Y, Gu S, Tang K. A systematic review and meta-analysis of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) versus traditional staged hepatectomy. Medicine (Baltimore). 2019;98:e15229.","journal-title":"Medicine (Baltimore)"},{"key":"1710_CR46","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00268-017-4181-6","volume":"42","author":"D Moris","year":"2018","unstructured":"Moris D, Ronnekleiv-Kelly S, Kostakis ID, Tsilimigras DI, Beal EW, Papalampros A, Dimitroulis D, Felekouras E, Pawlik TM. Operative results and oncologic outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) versus two-stage hepatectomy (TSH) in patients with unresectable colorectal liver metastases: a systematic review and meta-analysis. World J Surg. 2018;42:806\u201315.","journal-title":"World J Surg"},{"key":"1710_CR47","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1007\/s00330-016-4291-9","volume":"26","author":"B Guiu","year":"2016","unstructured":"Guiu B, Chevallier P, Denys A, Delhom E, Pierredon-Foulongne MA, Rouanet P, Fabre JM, Quenet F, Herrero A, Panaro F, et al. Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique. Eur Radiol. 2016;26:4259\u201367.","journal-title":"Eur Radiol"},{"key":"1710_CR48","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1007\/s00268-015-3194-2","volume":"39","author":"S Hwang","year":"2015","unstructured":"Hwang S, Ha TY, Ko GY, Kwon DI, Song GW, Jung DH, Kim MH, Lee SK, Lee SG. Preoperative sequential portal and hepatic vein embolization in patients with hepatobiliary malignancy. World J Surg. 2015;39:2990\u20138.","journal-title":"World J Surg"},{"key":"1710_CR49","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/SLA.0b013e31819ecc5c","volume":"249","author":"S Hwang","year":"2009","unstructured":"Hwang S, Lee SG, Ko GY, Kim BS, Sung KB, Kim MH, Lee SK, Hong HN. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg. 2009;249:608\u201316.","journal-title":"Ann Surg"},{"key":"1710_CR50","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1097\/SLA.0b013e318265fd3e","volume":"256","author":"TA Aloia","year":"2012","unstructured":"Aloia TA, Vauthey JN. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost? Ann Surg. 2012;256:e9; author reply e16-19.","journal-title":"Ann Surg"},{"key":"1710_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.amjsurg.2017.08.013","volume":"215","author":"DKA Chia","year":"2018","unstructured":"Chia DKA, Yeo Z, Loh SEK, Iyer SG, Bonney GK, Madhavan K, Kow AWC. Greater hypertrophy can be achieved with associating liver partition with portal vein ligation for staged hepatectomy compared to conventional staged hepatectomy, but with a higher price to pay? Am J Surg. 2018;215:131\u20137.","journal-title":"Am J Surg"},{"key":"1710_CR52","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1245\/s10434-015-5007-0","volume":"23","author":"JG D'Haese","year":"2016","unstructured":"D'Haese JG, Neumann J, Weniger M, Pratschke S, Bjornsson B, Ardiles V, Chapman W, Hernandez-Alejandro R, Soubrane O, Robles-Campos R, et al. Should ALPPS be used for liver resection in intermediate-stage HCC? Ann Surg Oncol. 2016;23:1335\u201343.","journal-title":"Ann Surg Oncol"},{"key":"1710_CR53","doi-asserted-by":"publisher","first-page":"703","DOI":"10.7314\/APJCP.2014.15.2.703","volume":"15","author":"C Xu","year":"2014","unstructured":"Xu C, Lv PH, Huang XE, Wang SX, Sun L, Wang FA, Wang LF. Safety and efficacy of sequential transcatheter arterial chemoembolization and portal vein embolization prior to major hepatectomy for patients with HCC. Asian Pac J Cancer Prev. 2014;15:703\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1710_CR54","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1477-2574.2012.00492.x","volume":"14","author":"PD Peng","year":"2012","unstructured":"Peng PD, Hyder O, Bloomston M, Marques H, Corona-Villalobos C, Dixon E, Pulitano C, Hirose K, Schulick RD, Barroso E, et al. Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignancies. HPB (Oxford). 2012;14:523\u201331.","journal-title":"HPB (Oxford)"},{"key":"1710_CR55","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1349-7006.2009.01363.x","volume":"101","author":"L Liu","year":"2010","unstructured":"Liu L, Ren ZG, Shen Y, Zhu XD, Zhang W, Xiong W, Qin Y, Tang ZY. Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model: relevance of epithelial-mesenchymal transition. Cancer Sci. 2010;101:120\u20138.","journal-title":"Cancer Sci"},{"key":"1710_CR56","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jfma.2011.12.009","volume":"111","author":"WL Tsai","year":"2012","unstructured":"Tsai WL, Liang PC, Chen CH. Tumor lysis syndrome after transarterial chemoembolization plus portal venous embolization for hepatocellular carcinoma. J Formos Med Assoc. 2012;111:724\u20135.","journal-title":"J Formos Med Assoc"},{"key":"1710_CR57","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/j.amjmed.2016.04.019","volume":"129","author":"RD Jiang","year":"2016","unstructured":"Jiang RD, Jian WC, Jin N, Zhang ZL, Li T. Tumor lysis syndrome: a serious complication of transcatheter arterial chemoembolization for hepatocellular carcinoma. Am J Med. 2016;129:e173\u20136.","journal-title":"Am J Med"},{"key":"1710_CR58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/hepr.12498","volume":"46","author":"H Yoshida","year":"2016","unstructured":"Yoshida H, Mamada Y, Taniai N, Uchida E. Spontaneous ruptured hepatocellular carcinoma. Hepatol Res. 2016;46:13\u201321.","journal-title":"Hepatol Res"},{"key":"1710_CR59","doi-asserted-by":"publisher","first-page":"7302","DOI":"10.3748\/wjg.v18.i48.7302","volume":"18","author":"Q Zhu","year":"2012","unstructured":"Zhu Q, Li J, Yan JJ, Huang L, Wu MC, Yan YQ. Predictors and clinical outcomes for spontaneous rupture of hepatocellular carcinoma. World J Gastroenterol. 2012;18:7302\u20137.","journal-title":"World J Gastroenterol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-019-1710-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-019-1710-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-019-1710-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T23:10:52Z","timestamp":1601939452000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-019-1710-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,7]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1710"],"URL":"https:\/\/doi.org\/10.1186\/s12957-019-1710-9","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,7]]},"assertion":[{"value":"15 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the ethics committee of the Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The study was undertaken with the patient\u2019s consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"167"}}